These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 7689813

  • 1. NK cells and interferon as mediators of biological response modifier-mediated protection against MCMV and HSV-2 infection in normal and immunocompromised mice.
    Kunder SC, Morahan PS.
    Ann N Y Acad Sci; 1993 Jun 23; 685():618-9. PubMed ID: 7689813
    [No Abstract] [Full Text] [Related]

  • 2. Biological response modifier-mediated resistance to herpesvirus infections requires induction of alpha/beta interferon.
    Kunder SC, Kelly KM, Morahan PS.
    Antiviral Res; 1993 Jun 23; 21(2):129-39. PubMed ID: 7687839
    [Abstract] [Full Text] [Related]

  • 3. The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1.
    Bukowski JF, Welsh RM.
    J Immunol; 1986 May 01; 136(9):3481-5. PubMed ID: 2420892
    [Abstract] [Full Text] [Related]

  • 4. Role of NK cells in immunomodulator-mediated resistance to herpesvirus infection.
    Kunder SC, Wu L, Morahan PS.
    Antiviral Res; 1993 Jun 01; 21(2):103-18. PubMed ID: 8393316
    [Abstract] [Full Text] [Related]

  • 5. Role of interferon in the resistance of C3H/HeJ mice to infection with herpes simplex virus.
    Chmielarczyk W, Domke I, Kirchner H.
    Antiviral Res; 1985 Feb 01; 5(1):55-9. PubMed ID: 2580483
    [Abstract] [Full Text] [Related]

  • 6. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
    Bukowski JF, Welsh RM.
    J Immunol; 1985 Nov 01; 135(5):3537-41. PubMed ID: 2413125
    [Abstract] [Full Text] [Related]

  • 7. Experimental infection of inbred mice with herpes simplex virus. II. Interferon production and activation of natural killer cells in the peritoneal exudate.
    Engler H, Zawatzky R, Goldbach A, Schröder CH, Weyand C, Hämmerling GJ, Kirchner H.
    J Gen Virol; 1981 Jul 01; 55(Pt 1):25-30. PubMed ID: 6170726
    [Abstract] [Full Text] [Related]

  • 8. Studies of cellular immunity, serum interferon titers, and natural killer cell activity in schizophrenic patients.
    Schindler L, Leroux M, Beck J, Moises HW, Kirchner H.
    Acta Psychiatr Scand; 1986 Jun 01; 73(6):651-7. PubMed ID: 2428210
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Protection against murine cytomegalovirus infection in aged mice and mice with severe combined immunodeficiency disease with the biological response modifiers polyribosinic-polycytidylic acid stabilized with L-lysine and carboxymethylcellulose, maleic anhydride divinyl ether and colony stimulating factor 1.
    Kunder SC, Wu L, Morahan PS.
    Antiviral Res; 1993 Jul 01; 21(3):233-45. PubMed ID: 7692814
    [Abstract] [Full Text] [Related]

  • 12. Role of interferon in human natural killer activity against target cells infected with HSV-1.
    Bishop GA, Glorioso JC, Schwartz SA.
    J Immunol; 1983 Oct 01; 131(4):1849-53. PubMed ID: 6194217
    [Abstract] [Full Text] [Related]

  • 13. Herpes simplex virus - induced interferon production and activation of natural killer cells in SM/J mice. Relation to antiviral resistance.
    Chmielarczyk W, Engler H, Brücher J, Kirchner H.
    Antiviral Res; 1983 Dec 01; 3(5-6):325-33. PubMed ID: 6200068
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Interferon as a defence mechanism in mouse cytomegalovirus infection.
    Chong KT, Gresser I, Mims CA.
    J Gen Virol; 1983 Feb 01; 64 (Pt 2)():461-4. PubMed ID: 6187894
    [Abstract] [Full Text] [Related]

  • 16. Enhancement of susceptibility of HSV-1-infected cells to natural killer lysis by interferon.
    Muñoz A, Carrasco L, Fresno M.
    J Immunol; 1983 Aug 01; 131(2):783-7. PubMed ID: 6190939
    [Abstract] [Full Text] [Related]

  • 17. Relationship between expression of herpes simplex virus glycoproteins and susceptibility of target cells to human natural killer activity.
    Bishop GA, Glorioso JC, Schwartz SA.
    J Exp Med; 1983 May 01; 157(5):1544-61. PubMed ID: 6189940
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Natural killer activity against viral targets in cyclosporine-treated renal allograft recipients.
    Cauda R, Citterio F, Tamburrini E, Pozzetto U, Tumbarello M, Castagneto M, Ortona L.
    Transplant Proc; 1988 Apr 01; 20(2 Suppl 2):186-9. PubMed ID: 2834839
    [No Abstract] [Full Text] [Related]

  • 20. Injection of anti-thy-1.2 serum breaks genetic resistance of mice against herpes simplex virus.
    Chmielarczyk W, Engler H, Ernst R, Opitz U, Kirchner H.
    J Gen Virol; 1985 May 01; 66 ( Pt 5)():1087-94. PubMed ID: 2582081
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.